NEW YORK, March 18, 2014 /PRNewswire/ --
On Monday, March 17, 2014, the
NASDAQ Composite finished at 4,279.95, up 0.81%. The Dow Jones
Industrial Average closed the session at 16,247.22, up 1.13% and
the S&P 500 ended the day at 1,858.83, higher by 0.96%. The
gains were broad based as all the sectors ended the session in
positive. Investor-Edge.com looks at some of the equities that hit
a new 52-week high during the last session. These include NextEra
Energy Inc. (NYSE:NEE), Silver Standard Resources Inc.
(NASDAQ:SSRI), Wisconsin Energy Corporation (NYSE MKT: WEC), and
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Free research on these
four companies can be accessed at:
http://investor-edge.com/register
On Monday, NextEra Energy Inc.'s stock closed at $94.81, up 0.58%, hitting a new 52-week high of
$95.07. The stock recorded a trading
volume of 1.82 million shares, compared with the three-month
average volume of 2.11 million shares. NextEra Energy Inc.'s shares
were traded at a PE ratio of 19.13 and were up 10.73% on YTD basis.
Shares of the company have advanced 2.84% in the past three trading
sessions and surged 14.74% in the last three months. The stock has
witnessed a gain of 1.65% in the last one month. The S&P 500
Utilities sector Index mapped a gain of 0.62% during the session
while the same has charted up by 9.41% during the last three
months. The stock is trading above its 50-day and 200-day moving
averages. NextEra Energy Inc.'s 50-day moving average of
$89.80 is above the 200-day moving
average of $84.49. Moreover, the
company's shares were trading at the Relative Strength Index (RSI)
of 65.53. Sign up and read the free notes on NEE at:
http://www.Investor-Edge.com/03182014/NEE/report.pdf
Silver Standard Resources Inc.'s stock fluctuated in the range
of $11.37 and $12.21 during Monday's session, hitting a new
52-week high of $12.21. The stock
reported a loss of 1.64%, ending the day at $11.38. A total of 5.19 million shares were
traded, which is above the 3-month average volume of 1.95 million
shares. The company's shares have surged 10.16% in the last one
month and 64.93% in the previous three months. The S&P 500
Materials sector Index posted gains of 2.39% in the last one month
and 6.65% in the previous three months. The company's shares have
advanced 63.51% on YTD basis. The company's shares are trading
above their 50-day and 200-day moving averages of $9.09 and $7.38,
respectively. The stock's RSI stood at 71.89. The complimentary
notes on SSRI can be downloaded as in PDF format at:
http://www.Investor-Edge.com/03182014/SSRI/report.pdf
On Monday, shares in Wisconsin Energy Corp. edged 0.77% higher
to finish the day at $45.66, hitting
a new 52-week high of $45.87. The
stock recorded a trading volume of 1.08 million shares, compared
with the three-month average volumes of 1.65 million shares during
the Monday's session. The company's shares traded at a PE ratio of
18.19 and were up 10.45% on YTD basis. Shares of Wisconsin Energy
Corp. have advanced 4.68% in the last one month and 11.91% in the
previous three months. The S&P 500 Utilities sector Index
mapped a gain of 0.62% during the session and the same has advanced
9.41% during the last three months. The stock is trading above its
50-day and 200-day moving averages of $42.54 and $41.72,
respectively. Furthermore, the company's shares were trading at the
Relative Strength Index (RSI) of 70.89. Register for free on
Investor-Edge and access the latest research on WEC at:
http://www.Investor-Edge.com/03182014/WEC/report.pdf
Shares in Vanda Pharmaceuticals Inc. finished Monday's session
at $18.03, reporting a 2.15% gain
after hitting new 52-weeks high of $18.48. A total of 0.64 million shares were
traded, as compared to the three months average volume of 1.17
million shares. The company's stock traded between $17.74 and $18.48 during the trading session. The
company's shares have surged 33.95% in the last one month and
64.66% in the previous three months. Vanda Pharmaceuticals Inc.'s
stocks have advanced 45.29% on YTD basis. The S&P 500 Health
Care sector Index mapped a gain of 0.91% during the session and
charted up by 9.89% during the previous three months. The stock is
trading above its 50-day and 200-day moving averages. The company's
50-day moving average of $13.53 is
above the 200-day moving average of $11.07. The RSI of Vanda Pharmaceuticals Inc.
stood at 74.37. The complete research on VNDA is available for free
at:
http://www.Investor-Edge.com/03182014/VNDA/report.pdf
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and
reliable way to leverage our economy of scale. Most investors do
not have time to track all publicly traded companies, much less
perform an in-depth review and analysis of the complexities
contained in each situation. That's where Investor-Edge comes in.
We provide a single unified platform for investors' to hear about
what matters. Situation alerts, moving events, and upcoming
opportunities.
=============
EDITOR NOTES:
=============
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] Investor-edge.com.
-
For any urgent concerns or inquiries,
please contact us at compliance [at] Investor-edge.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] Investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.Investor-Edge.com/
SOURCE Investor-Edge